The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy
Open accessAbstract
Treatment of class V+IV lupus nephritis remains unsatisfactory despite the progress made in the treatment of diffuse proliferative lupus nephritis. In this prospective study, 40 patients with class V+IV lupus nephritis were randomly assigned to induction therapy with mycophenolate mofetil, tacrolimus, and steroids (multitarget therapy) or intravenous cyclophosphamide (IVCY). Patients were treated for 6 mo unless complete remission was not achieved, in which case treatment was extended to 9 mo. An intention-to-treat analysis revealed a higher rate of complete remission with multitarget therapy at both 6 and 9 mo (50 and 65%, respectively) than with IVCY (5 and 15%, respectively). At 6 mo, eight (40%) patients in each group experienced partial remission, and at 9 mo, six (30%) patients receiving multitarget therapy and eight (40%) patients receiving IVCY experienced partial remission. There were no deaths during this study. Most adverse events were less frequent in the multitarget therapy group. Calcineurin inhibitor nephrotoxicity was not observed, but three patients developed new-onset hypertension with multitarget therapy. In conclusion, multitarget therapy is superior to IVCY for inducing complete remission of class V+IV lupus nephritis and is well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
Weening, J. J., D’Agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A., Cook, T., Ferrario, F., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000108969.21691.5d · Cited by 2,008
Efficacy of Mycophenolate Mofetil in Patients with Diffuse Proliferative Lupus Nephritis
Chan, T. M., Li, F. K., Tang, C. S. O., Wong, R. W. S., Fang, G. X., Ji, Y. L., Lau, C. S., Wong, A. K. M., Tong, M. K. L., Chan, K. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431604 · Cited by 954
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., & Balow, J. E. (1984) · Kidney International · doi:10.1038/ki.1984.75 · Cited by 718
Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology
Nankivell, B. J., Borrows, R. J., Fung, C. L.-S., O'Connell, P. J., Chapman, J. R., & Allen, R. D. M. (2004) · Transplantation · doi:10.1097/01.tp.0000128636.70499.6e · Cited by 498
Tacrolimus: A Further Update of its Use in the Management of Organ Transplantation
Scott, L. J., McKeage, K., Keam, S. J., & Plosker, G. L. (2003) · Drugs · doi:10.2165/00003495-200363120-00006 · Cited by 422
Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF)
Allison, A. C., & Eugui, E. M. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00651.x · Cited by 376
Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis
Holdsworth, S. R., Kitching, A. R., & Tipping, P. G. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00369.x · Cited by 262
Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level.
Andersson, J., Nagy, S., Groth, C. G., & Andersson, J. (1992) · PubMed Central · Cited by 151
Therapeutic monitoring of mycophenolic acid
Shaw, L. M. J., Nicholls, A. J., Hale, M., Armstrong, V. W., Oellerich, M., Yatscoff, R., Morris, R. E., Holt, D. W., Venkataramanan, R., Haley, J., et al. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00040-x · Cited by 127
Sinclair, A., Appel, G. B., Dooley, M. A., Ginzler, E. M., Isenberg, D. A., Jayne, D. R. W., Wofsy, D., & Solomons, N. (2007) · Lupus · doi:10.1177/0961203307084712 · Cited by 117
Cited by
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215089 · Cited by 2,011
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Rovin, B. H., Ayoub, I. M., Chan, T. M., Liu, Z.-H., Mejía-Vilet, J. M., & Floege, J. (2024) · Kidney International · doi:10.1016/j.kint.2023.09.002 · Cited by 517
Self-citationLiu, Z.-H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.146 · Cited by 258
Self-citation
Metadata
- Authors
- Bao, H., Liu, Z.-H., Xie, H.-L., Hu, W.-X., Zhang, H.-T., & Li, L.-S.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2008-10
- Volume
- 19
- Issue
- 10
- Pages
- 2001-2010
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2148306888
- Cited by
- 301
- References
- 15
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy. https://app.cochat.ai/papers/10.1681/asn.2007121272
- The paper
- Bao, H., Liu, Z.-H., Xie, H.-L., Hu, W.-X., Zhang, H.-T., & Li, L.-S. (2008). Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2007121272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.